P1.15-12. Patient-reported Outcomes of Cemiplimab versus Chemotherapy in Advanced NSCLC: PD-L1 Level Subgroups in EMPOWER-Lung 1
Back to course
Pdf Summary
Asset Subtitle
Saadettin Kilickap, Turkey
Meta Tag
Speaker Saadettin Kilickap, Turkey
Topic Metastatic Non-small Cell Lung Cancer – Immunotherapy
advanced non-small cell lung cancer
PD-L1 levels
patient-reported outcomes
global health status
quality of life
lung cancer-specific functions
EORTC Quality of Life-Core 30
Powered By